# Central Serous Chorioretinopathy Treated by Modified Photodynamic Therapy

> **NCT01019668** · NA · COMPLETED · sponsor: **Shin Kong Wu Ho-Su Memorial Hospital** · enrollment: 24 (actual)

## Conditions studied

- Central Serous Chorioretinopathy

## Interventions

- **DRUG:** Verteporfin PDT, half-dose
- **DRUG:** verteporfin PDT, half-fluence

## Key facts

- **NCT ID:** NCT01019668
- **Lead sponsor:** Shin Kong Wu Ho-Su Memorial Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-11
- **Primary completion:** 2009-12
- **Final completion:** 2011-06
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2011-07-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01019668

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01019668, "Central Serous Chorioretinopathy Treated by Modified Photodynamic Therapy". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT01019668. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*